Nuclear medicine and radiotherapy in the clinical management of glioblastoma patients

被引：1

作者：

Nardone, Valerio ^{[1
]}

Desideri, Isacco ^{[2
]}

D'Ambrosio, Luca ^{[1
]}

Morelli, Ilaria ^{[2
]}

Visani, Luca ^{[2
]}

Di Giorgio, Eugenio ^{[3
]}

Guida, Cesare ^{[4
]}

Clemente, Alfredo ^{[1
]}

Belfiore, Maria Paola ^{[1
]}

Cioce, Fabrizio ^{[1
]}

Spadafora, Marco ^{[3
]}

Vinciguerra, Claudia ^{[5
]}

Mansi, Luigi ^{[6
]}

Reginelli, Alfonso ^{[1
]}

Cappabianca, Salvatore ^{[1
]}

机构：

[1] Univ Campania L Vanvitelli, Dept Precis Med, I-80138 Naples, Italy

[2] Univ Florence, Dept Biomed Expt & Clin Sci M Serio, Florence, Italy

[3] Osped MareASL Napoli 1 Ctr, Unit Nucl Med, Naples, Italy

[4] Osped MareASL Napoli 1 Ctr, Unit Radiat Oncol, Naples, Italy

[5] Univ Hosp Salerno, Unit Neurol, Salerno, Italy

[6] Interuniv Res Ctr Sustainabil CIRPS, Sect Hlth & Dev, Rome, Italy

来源：

CLINICAL AND TRANSLATIONAL IMAGING | 2022年 / 10卷 / 05期

关键词：

Glioblastoma; Nuclear medicine; PET; CT; Oncology; Precision medicine; Radiotherapy; POSITRON-EMISSION-TOMOGRAPHY; HIGH-GRADE GLIOMAS; PHASE-II TRIAL; AMINO-ACID PET; RADIATION-THERAPY; BRAIN-TUMORS; FDG-PET; TARGET DELINEATION; MALIGNANT GLIOMAS; PROGNOSTIC VALUE;

D O I：

10.1007/s40336-022-00495-8

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Introduction The aim of the narrative review was to analyse the applications of nuclear medicine (NM) techniques such as PET/CT with different tracers in combination with radiotherapy for the clinical management of glioblastoma patients. Materials and methods Key references were derived from a PubMed query. Hand searching and clinicaltrials.gov were also used. Results This paper contains a narrative report and a critical discussion of NM approaches in combination with radiotherapy in glioma patients. Conclusions NM can provide the Radiation Oncologist several aids that can be useful in the clinical management of glioblastoma patients. At the same, these results need to be validated in prospective and multicenter trials.

引用

页码：477 / 493

页数：17

共 115 条

[1] TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma
Albert, Nathalie L.
Unterrainer, M.
Fleischmann, D. F.
Lindner, S.
Vettermann, F.
Brunegraf, A.
Vomacka, L.
Brendel, M.
Wenter, V.
Wetzel, C.
Rupprecht, R.
Tonn, J. -C.
Belka, C.
Bartenstein, P.
Niyazi, M.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (13) : 2230 - 2238
[2] Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
Albert, Nathalie L.
Weller, Michael
Suchorska, Bogdana
Galldiks, Norbert
Soffietti, Riccardo
Kim, Michelle M.
La Fougere, Christian
Pope, Whitney
Law, Ian
Arbizu, Javier
Chamberlain, Marc C.
Vogelbaum, Michael
Ellingson, Ben M.
Tonn, Joerg C.
[J]. NEURO-ONCOLOGY, 2016, 18 (09) : 1199 - 1208
[3] Intensity-modulated radiation therapy in newly diagnosed glioblastoma: A systematic review on clinical and technical issues
Amelio, Dante
Lorentini, Stefano
Schwarz, Marco
Amichetti, Maurizio
[J]. RADIOTHERAPY AND ONCOLOGY, 2010, 97 (03) : 361 - 369
[4] POST-OPERATIVE IRRADIATION OF GLIOBLASTOMAS - RESULTS IN A RANDOMIZED SERIES
ANDERSEN, AP
[J]. ACTA RADIOLOGICA ONCOLOGY, 1978, 17 (06): : 475 - 484
[5] Cost-Effectiveness of [18F] Fluoroethyl-L-Tyrosine for Temozolomide Therapy Assessment in Patients With Glioblastoma
Baguet, Tristan
Verhoeven, Jeroen
De Vos, Filip
Goethals, Ingeborg
[J]. FRONTIERS IN ONCOLOGY, 2019, 9
[6] Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
Baumert, Brigitta G.
Hegi, Monika E.
van den Bent, Martin J.
von Deimling, Andreas
Gorlia, Thierry
Hoang-Xuan, Khe
Brandes, Alba A.
Kantor, Guy
Taphoorn, Martin J. B.
Ben Hassel, Mohamed
Hartmann, Christian
Ryan, Gail
Capper, David
Kros, Johan M.
Kurscheid, Sebastian
Wick, Wolfgang
Enting, Roelien
Reni, Michele
Thiessen, Brian
Dhermain, Frederic
Bromberg, Jacoline E.
Feuvret, Loic
Reijneveld, Jaap C.
Chinot, Olivier
Gijtenbeek, Johanna M. M.
Rossiter, John P.
Dif, Nicolas
Balana, Carmen
Bravo-Marques, Jose
Clement, Paul M.
Marosi, Christine
Tzuk-Shina, Tzahala
Nordal, Robert A.
Rees, Jeremy
Lacombe, Denis
Mason, Warren P.
Stupp, Roger
[J]. LANCET ONCOLOGY, 2016, 17 (11) : 1521 - 1532
[7] [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis
Bekaert, Lien
Valable, Samuel
Lechapt-Zalcman, Emmanuele
Ponte, Keven
Collet, Solene
Constans, Jean-Marc
Levallet, Guenaelle
Bordji, Karim
Petit, Edwige
Branger, Pierre
Emery, Evelyne
Manrique, Alain
Barre, Louisa
Bernaudin, Myriam
Guillamo, Jean-Sebastien
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (08) : 1383 - 1392
[8] Increasing feasibility and utility of 18F-FDOPA PET for the management of glioma
Bell, Christopher
Dowson, Nicholas
Puttick, Simon
Gal, Yaniv
Thomas, Paul
Fay, Mike
Smith, Jye
Rose, Stephen
[J]. NUCLEAR MEDICINE AND BIOLOGY, 2015, 42 (10) : 788 - 795
[9] The role of F-18-fluorothymidine PET in oncology
Bertagna F.
Biasiotto G.
Giubbini R.
[J]. Clinical and Translational Imaging, 2013, 1 (2) : 77 - 97
[10] Birsen Rudy, 2018, Oncotarget, V9, P16822, DOI 10.18632/oncotarget.24706

← 1 2 3 4 5 6 7 8 9 10 →